Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti-PD-1 Therapy.

ABSTRACT:

SUBMITTER: Lochrin SE 

PROVIDER: S-EPMC11783241 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature